B2DB — Who said what, where, and when

Further Investigation of the Origin of Clear Cell Adenocarcinoma of Urinary Tract by Immunostains for Kidney Injury Molecule-1 (KIM1) and CD133 (A Stem Cell Marker)

2026 ASCP/CAP-ACP Annual Meeting · 19 November 2026 · 12:30–13:15 · 517ABC - Exhibit Hall

Further Investigation of the Origin of Clear Cell Adenocarcinoma of Urinary Tract by Immunostains for Kidney Injury Molecule-1 (KIM1) and CD133 (A Stem Cell Marker) was a session at 2026 ASCP/CAP-ACP Annual Meeting on 19 November 2026 in Montreal, with 1 speaker on record.

Speakers